HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hereditary spastic paraplegia: identification of an SPG3A gene mutation in a Chinese family.

Abstract
Hereditary spastic paraplegias are a heterogeneous group of chronic central motor system disorders, characterised by progressive lower limb spasticity. Hereditary spastic paraplegia is clinically classified into pure and complicated forms, by the absence or presence of additional neurological or extra-neurological features. Hereditary spastic paraplegias follow all modes of inheritance and the pure-form autosomal dominant type is the one most commonly reported. Spastic paraplegia 4, autosomal dominant (SPG4, MIM#182601) and spastic paraplegia 3, autosomal dominant (SPG3A, MIM#182600), account for most autosomal dominant hereditary spastic paraplegias. Using DNA mutation analysis, the authors identified an SPG3A missense mutation (p.R239C) in a Chinese family where three members have early-onset pure spastic paraplegia. To our knowledge, this is the first report of a gene mutation in hereditary spastic paraplegias in our locality. DNA-based diagnosis plays a key role in the early diagnosis of familial hereditary spastic paraplegias.
AuthorsK Y Chan, C K Ching, Chloe M Mak, C W Lam, Albert Y W Chan
JournalHong Kong medical journal = Xianggang yi xue za zhi (Hong Kong Med J) Vol. 15 Issue 4 Pg. 304-7 (Aug 2009) ISSN: 1024-2708 [Print] China
PMID19652243 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Membrane Proteins
  • ATL1 protein, human
  • GTP Phosphohydrolases
  • GTP-Binding Proteins
Topics
  • Age of Onset
  • Child
  • China
  • DNA Mutational Analysis
  • GTP Phosphohydrolases (genetics)
  • GTP-Binding Proteins
  • Humans
  • Male
  • Membrane Proteins
  • Mutation, Missense
  • Pedigree
  • Phenotype
  • Spastic Paraplegia, Hereditary (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: